According to Pulmatrix's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.38351. At the end of 2022 the company had a P/E ratio of -0.7106.
Year | P/E ratio | Change |
---|---|---|
2022 | -0.7106 | -30.15% |
2021 | -1.02 | -45.15% |
2020 | -1.86 | 221.39% |
2019 | -0.5772 | 32.51% |
2018 | -0.4356 | -71.21% |
2017 | -1.51 | 379.5% |
2016 | -0.3155 | -45.78% |
2015 | -0.5819 | -74.56% |
2014 | -2.29 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() | -5.22 | 277.46% | ๐บ๐ธ USA |
![]() | -36.8 | 2,556.78% | ๐บ๐ธ USA |
![]() | -9.54 | 589.45% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.